|Articles|February 1, 2011
- Pharmaceutical Executive-02-01-2011
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - February 2011
The Promise Of Translational Medicine
Advertisement
Articles in this issue
almost 15 years ago
Skipping the Needle: Pharm Exec's Brand of the Yearalmost 15 years ago
Honing Reforms from Clinical Developmentalmost 15 years ago
Growing Stronger After the StormNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Targeting CCR5 Receptors
2
Merck to Acquire Cidara for $9.2 Billion
3
Komzifti Gains FDA Approval, Giving Kura Oncology and Kyowa Kirin a Key Strategic Win in NPM1-Mutated AML
4
Invictus Pharmacy Becomes First US Pharmacy to Accept Cryptocurrency for Prescriptions
5
